Arthritis Research & Therapy

official impact factor 4.36

DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis

Piet LCM van Riel* and Jaap Fransen

Arthritis Research & Therapy 2005, 7:189-190 doi:10.1186/ar1820


See related research article http://arthritis-research.com/content/7/5/R1063

Accesses  

  • Last 30 days: 61 accesses
  • Last 365 days: 1275 accesses
  • All time: 7523 accesses

Cited by

BioMed Central: 2 citations